Treatment for systemic lupus erythematosus

Details Treatment for systemic lupus erythematosus Treatment for systemic lupus erythematosus

1995-06-05

1997-10-21

Reamer, James H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

A61K 3170

Patent

active

056796510

ABSTRACT:
Cytarabine (ara-C) is effective in the treatment of systemic lupus erythematosus.

REFERENCES:
Yung, et al., Rheum. Dis. Clin. North Am., 20:61 (1994).
Decker, et al., Ann. Intern. Med., 91:587 (1979).
Quddus, et al., J. Clin. Invest. 92:38 (1993).
Yung, et al., J. Immunol., 154:3025-3035 (1995).
Nyce, et al. (Nucleic Acids Research, 14(10):4353-4367 (1986).
Physicians' Desk Reference, 48th Edition, (Medical Economics Data Production Co., Montvale, NJ), 2405-2407 (1994).
Richardson, et al., Arthritis and Rheumatism, 35(6):647-62 (1992).
Richardson, et al., Arthritis and Rheumatism, 33(11):1665-73 (1990).
Krupp, et al., Ann. Neurol., 17(4):344-9 (1985).
Harris, et al., Int. J. Radiat. Biol. Relat. Stud. Phys. Chem Med., 47(6):689-99 (1985).
Kurki, et al., Exp. Cell Res., 166(1):209-19 (1986).
Bayliss, et al., Clin Exp. Rheumatol., 10:420-421 (1992).

Affiliated with

Also associated with

Rating

Treatment for systemic lupus erythematosus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for systemic lupus erythematosus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for systemic lupus erythematosus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1006782